Facebook Twitter
Unlock all content!
ESHIᴹᵀ
  • About ESHIᴹᵀ
    • Society
    • National Ambassadors
    • Contact
  • Membership
  • AI Challenge
  • Education
    • CHILI 2026
    • Webinars
    • Recordings
    • Fellowship
  • Cases / Stories / Maps
    • Cases
    • Storyboard
    • PET/MR map
    • PET/CT map
  • Sponsors
Select Page
2026.04 – Imaging and radionuclide therapy using the gastrin-releasing peptide receptor (GRPR) antagonist NeoB

2026.04 – Imaging and radionuclide therapy using the gastrin-releasing peptide receptor (GRPR) antagonist NeoB

by ESHI | Apr 17, 2026

2026.04 – Imaging and radionuclide therapy using the gastrin-releasing peptide receptor (GRPR) antagonist NeoB

2026.03 – Hyperpolarised carbon-13 MRI in breast and ovarian cancer

by ESHI | Apr 2, 2026

2026.04 – Imaging and radionuclide therapy using the gastrin-releasing peptide receptor (GRPR) antagonist NeoB

2026.02 – Total-Body PETCT in oncology – clinical consideration

by ESHI | Feb 9, 2026

2025.11 – Imaging of lymphomas: current status

2025.11 – Imaging of lymphomas: current status

by ESHI | Nov 5, 2025

CHILI 8.0 – Session 5 – THERANOSTICS

CHILI 8.0 – Session 5 – THERANOSTICS

by ESHI | Nov 4, 2025

« Older Entries

Contact

ESHIMT
European Society for Hybrid, Molecular and Translational Imaging

Am Gestade 1 | 1010 Vienna | Austria
p +43 1 533 40 64 903 | f +43 1 5334064-445
office@eshi-society.org | www.eshi-society.org
ZVR 703077733

Legal Disclaimer

Read more here

Data Protection Information

Read more here

Social Media

Login to ePortal